Amgen, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Amgen, Inc., formerly Applied Molecular Genetics Inc., works to make biologic medicines using living cells. It is a biotechnology company that discovers, develops, and manufactures therapeutics that help cancer patients, rheumatoid arthritis patients, and patients with autoimmune diseases.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Amgen is a net-positive Humankind Value company thanks to its Healthcare R&D ($180.8 B), Pharmaceuticals ($75.9 B), and Economic Value ($9.2 B). Healthcare is a central component of our measure of Humankind Value, as the last 150 years of medical innovation have contributed to modern life expectancies. The company produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. The value it adds through its work in Healthcare R&D and Pharmaceuticals includes an estimated 5,327,703.0 additional years of life for people worldwide. This firm can increase its Humankind Value by addressing Greenhouse Gases (-$1.1 B) and Air Pollution (-$241.6 M). Healthcare R&D, Pharmaceuticals, and Economic Value, as well as Greenhouse Gases, and Air Pollution, are attached to this company because of its direct business activities.